The deal to provide life-changing drugs to cystic fibrosis sufferers will cost the state close to €400 million over ten years.
The HSE and the drug’s maker Vertex have reached a deal in principle on providing the drugs Orkambi and Kalydeco to CF patients, but the final terms and conditions are still being worked out.
The final cost will be approved by ministers at a cabinet meeting before the end of the month,...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team